[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651786":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":29,"locations":30,"responsibleParty":50,"collaborators":53,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":29,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":29,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":76,"overallStatus":80,"whyStopped":29,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Indiana University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL","Eye-tracking device",[13],"Device: Eye-tracking device",[15],{"type":16,"name":11,"description":17,"armGroupLabels":18,"otherNames":19},"DEVICE","Eye-tracking device for autism detection",[9],[20],"Tobii Eye-Tracker 5L",[22,25,27],{"name":23,"affiliation":5,"role":24},"Pyone David, MD","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":5,"role":24},"Rebecca McNally Keehn, PhD",{"name":28,"affiliation":5,"role":24},"Edgardo Szyld, MD",null,[31],{"facility":32,"status":29,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Riley Hospital for Children","Indianapolis","Indiana","46202","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-86.15804,39.76838,{"lat":42,"lon":41},[45],{"name":46,"role":47,"phone":48,"phoneExt":29,"email":49},"Hannah Rykovich, RN","CONTACT","317-274-4708","hsrakow@iu.edu",{"type":24,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"Pyone David","Assistant Professor of Clinical Pediatrics",[54],{"name":55,"class":6},"Indiana University Health","100651786","eye-tracking-and-autism-in-former-preterm-infants-100651786",false,"NCT07764822","Eye Tracking and Autism in Former Preterm Infants","Eye-Tracking Biomarkers for Early Autism Detection in Former Preterm Infants","Inclusion Criteria:\n\n* Children born at \\\u003C37 weeks' gestational age who are 14-48 months old at time of referral\n* Ambulatory (i.e., cruising, walking)\n* Without significant visual impairment\n* Referred for autism testing through EYP (i.e. medium- or high-risk M-CHAT-R\u002FF screening result at 16-22 months corrected age or by referral to Early Years based on caregiver or provider concern for autism)\n\nExclusion Criteria:\n\n* Non-English-speaking participants and families.","ALL","14 Months","48 Months",{"count":67,"type":68},40,"ESTIMATED","INTERVENTIONAL",[71],"NA","This is a single center, intervention study of integrating the eye-tracking (ET) biomarker battery into the existing autism evaluation process at the Riley Early Years Program (EYP). Eligible participants referred for autism testing through EYP will undergo a traditional comprehensive diagnostic assessment by an EYP clinical psychologist.",[74,75],"Autism","Prematurity",[77,78,79],"autism","prematurity","eye tracking biomarkers","NOT_YET_RECRUITING","2026-08-10",{"date":83,"type":84},"2026-08-14","ACTUAL",{"date":86,"type":68},"2027-01-04",{"date":88,"type":68},"2028-01-03",{"name":5,"class":6},1]